Eli Lilly Rises, Shake Shack Declines, Abercrombie & Fitch Sinks

Stock Movers · Jan 12, 2026 · 5m

On this episode of Stock Movers:- Eli Lilly (LLY) said Monday it expects its highly anticipated weight-loss pill to receive US regulatory approval as early as the second quarter of 2026, slightly later than it signaled earlier. Drugmakers believe weight-loss pills could expand the market for popular GLP-1 medicines, which up until earlier this year were only sold as injections. In December, Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from Lilly.- Shake Shack (SHAK) shares slipped…